Ahg. Rasool et al., Ethnic differences in response to non-selective beta-blockade among racialgroups in Malaysia, INT J CL PH, 38(5), 2000, pp. 260-269
Citations number
40
Categorie Soggetti
Pharmacology & Toxicology
Journal title
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
<(Objective)under bar>: To determine whether racial differences in response
to blockade of beta receptors occur among racial groups in Malaysia that a
re the Malays, Indians and Chinese. <(Subjects, materials and method)under
bar>: 35 healthy male volunteers representing the 3 main racial groups in M
alaysia (12 Malays, 12 Chinese and 11 Indians) were studied in a randomized
, placebo-controlled, crossover and single-blind design. Propranolol 80 mg
12-hourly was given orally for 48 hours. Six hours after the last dose subj
ects attended an exercise session where resting and exercise heart rate, bl
ood pressure, plasma potassium and glucose levels, resting FEV1 and plasma
propranolol concentrations were recorded. <(Results)under bar>: No signific
ant difference in plasma propranolol (mean +/- SEM) levels was seen between
races six hours after the last dose (Malays, 59.7 +/- 8.8 ng/ml, Indians,
67.6 +/- 19.3 ng/ml, Chinese, 58.4 +/- 7.9 ng/ml). Chinese were least sensi
tive to the bradycardic and hypotensive effects of propranolol at rest and
exercise. Indians and Malays had significant reduction of supine systolic b
lood pressure with propranolol but not Chinese. Comparison of percentage re
ductions of systolic blood pressure at supine, sitting and exercise by repe
ated measure analysis showed the Malays to have significantly higher change
compared to the Chinese (p = 0.022). Similarly, comparison of percentage r
eductions of heart rate at supine, sitting and exercise by repeated measure
analysis showed the Malays to have significantly higher change compared to
the Chinese (p = 0.040). Average change in potassium concentrations at pea
k exercise and recovery showed the Indians to have significantly higher inc
rease in potassium levels with propranolol compared to the Malays (p = 0.03
8). However, no significant interethnic difference was seen in the reductio
n of glucose levels at rest, peak exercise or recovery. Also, no significan
t interethnic difference was seen in reduction of FEV1 values. <(Conclusion
)under bar>: We, therefore, conclude that ethnic differences in response to
blockade of P-receptors exist among racial groups in Malaysia. These diffe
rences were seen at similar plasma drug levels between races suggesting eth
nic differences in drug sensitivity, rather than differences in drug dispos
ition.